Company Data

Marizyme Inc

Ticker
MRZM
Current Price
$0.05
Market Cap
$6.6M
Price Target
Refer to Report
52wk Range
$0.004 - $0.1339
Advanced Market Data

Overview

Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. The company seeks to leverage healthcare innovations biomedical technologies such as DuraGraft, Krillase and MATLOCTM to address critical market gaps and offer transformative potential to wide range of issues including coronary artery bypass graft surgery, fat grafting, pet health, and chronic kidney disease.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy